Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped patients live longer without the disease progressing.

Itovebi won US Food and Drug Administration (FDA) approval in this breast cancer indication based on INAVO120’s data late last year, although full analysis of the OS has only been completed by ...

Roche (OTCQX:RHHBY) has received FDA approval for its drug Itovebi in combination with two other drugs for the treatment of a certain type of breast cancer with a PIK3CA mutation.

Roche and Lilly said they believe the test could play an important role in improving access to early and accurate Alzheimer's diagnosis.

Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new survival data to be presented at the upcoming ASCO congress looks set ...

Your cancer has grown while or after you took at least one other cancer hormonal medicine. Your doctor will test your cancer for gene changes and review your medical history to decide if Orserdu ...

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.

FDA approved a new method to screen for cervical cancer, using two self-screening tools.

Drs Kathy D. Miller and Sunil S. Badve discuss the importance of identifying HER2-low patients, those with ultra-low staining, and the benefit of targeted ADCs.

What Roche and Lilly are developing is a diagnostic immunoassay called elecsys phosphor-tau217 to detect proteins associated with Alzheimer’s disease in people 60 and older.